Lexapro and Eszopiclone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lexapro (escitalopram oxalate) and Eszopiclone (eszopiclone). Common drug interactions include conjunctivitis among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Lexapro and Eszopiclone. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.

What is Eszopiclone?

Eszopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 4,259 Eszopiclone users. Check the latest studies of Eszopiclone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

73 people who take Lexapro and Eszopiclone together, and have interactions are studied.

Lexapro and Eszopiclone drug interactions.

What are the common drug interactions of Lexapro and Eszopiclone, by gender? *:

female:

  1. Conjunctivitis (pink eye)
  2. Drug administration error
  3. Emotional distress
  4. Fall
  5. Gambling
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Oedema peripheral (superficial swelling)
  8. Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery)
  9. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  10. Postmenopausal haemorrhage (post-menopausal bleeding)

male:

  1. Fatigue (feeling of tiredness)
  2. Renal failure (kidney dysfunction)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Blood pressure increased
  5. Chest injury
  6. Chest pain
  7. Chronic kidney disease
  8. Confusional state
  9. Constipation
  10. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)

What are the common drug interactions of Lexapro and Eszopiclone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Septic shock (shock due to blood infection)

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Bone disorder
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Disability
  8. Fatigue (feeling of tiredness)
  9. Hypertension (high blood pressure)
  10. Muscular weakness (muscle weakness)

40-49:

  1. Dizziness
  2. Nausea (feeling of having an urge to vomit)
  3. Hypotension (abnormally low blood pressure)
  4. Pneumonia
  5. Vomiting
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Alopecia (absence of hair from areas of the body)
  8. Hair colour changes
  9. Hair disorder
  10. Renal failure (kidney dysfunction)

50-59:

  1. Fibrin d dimer increased
  2. Fracture displacement
  3. Gingival bleeding (bleeding gums)
  4. Haemangioma of liver (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in liver)
  5. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  6. Injection site cellulitis (injection site inflammation)
  7. Injection site thrombosis (injection site blood clotting)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Monoparesis (one limb is very weak, but not completely paralyzed)
  10. Neutropenia (an abnormally low number of neutrophils)

60+:

  1. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  2. Acne (skin problems that cause pimples)
  3. Oral mucosal erythema (redness of the mucous membrane of mouth)
  4. Rash macular (small, flat red spots)
  5. Skin lesion
  6. Small intestinal obstruction (blockage in small intestine)
  7. Stomatitis (inflammation of mucous membrane of mouth)
  8. Dyspnoea (difficult or laboured respiration)
  9. Herpes zoster
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 19.18%
  2. Pain: 11 people, 15.07%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 10.96%
  4. Sleep Disorder: 7 people, 9.59%
  5. Stress And Anxiety: 5 people, 6.85%
  6. Primary Myelofibrosis (primary disorder of the bone marrow): 4 people, 5.48%
  7. High Blood Pressure: 4 people, 5.48%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 5.48%

* Approximation only. Some reports may have incomplete information.

Do you take Lexapro and Eszopiclone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lexapro and Eszopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Eszopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lexapro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eszopiclone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate and eszopiclone (the active ingredients of Lexapro and Eszopiclone, respectively), and Lexapro and Eszopiclone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: